|
Report Date : |
09.10.2014 |
IDENTIFICATION DETAILS
|
Name : |
TEVA CANADA LIMITED |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
01.01.2001 |
|
|
|
|
Legal Form : |
Federal Corporation – Profit |
|
|
|
|
Line of Business : |
Subject develops, produces, and markets generic pharmaceuticals. |
|
|
|
|
No of Employees : |
1,400 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Canada |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CANADA -- ECONOMIC OVERVIEW
As a high-tech industrial
society in the trillion-dollar class, Canada resembles the US in its market-oriented
economic system, pattern of production, and high living standards. Since World
War II, the impressive growth of the manufacturing, mining, and service sectors
has transformed the nation from a largely rural economy into one primarily industrial
and urban. The 1989 US-Canada Free Trade Agreement (FTA) and the 1994 North
American Free Trade Agreement (NAFTA) (which includes Mexico) touched off a
dramatic increase in trade and economic integration with the US, its principal
trading partner. Canada enjoys a substantial trade surplus with the US, which
absorbs about three-fourths of Canadian merchandise exports each year. Canada
is the US's largest foreign supplier of energy, including oil, gas, uranium,
and electric power. Given its abundant natural resources, highly skilled labor
force, and modern capital plant, Canada enjoyed solid economic growth from 1993
through 2007. Buffeted by the global economic crisis, the economy dropped into
a sharp recession in the final months of 2008, and Ottawa posted its first
fiscal deficit in 2009 after 12 years of surplus. Canada's major banks,
however, emerged from the financial crisis of 2008-09 among the strongest in
the world, owing to the financial sector's tradition of conservative lending
practices and strong capitalization. Canada achieved marginal growth in 2010-13
and plans to balance the budget by 2015. In addition, the country's petroleum
sector is rapidly expanding, because Alberta's oil sands significantly boosted
Canada's proven oil reserves. Canada now ranks third in the world in proved oil
reserves behind Saudi Arabia and Venezuela.
|
Source
: CIA |
TEVA CANADA
LIMITED (in English
TEVA CANADA LIMITEE (in French)
Reg. address: 30 Novopharm Court, Toronto, Ontario
M1B 2K9- Canada
Telephone: +1
416-291-8876
Fax: +1 416-291-5555
Website: www.tevacanada.com
Corporate ID#: 7579829
State: Federal
Judicial form: Federal Corporation – Profit
A Federal Company is allowed to do business in
all the
Country
Date incorporated: 01-01-2001
Date founded: 1965
Stock: -
Value: -
Name of manager: Doug
SUMMERVILLE
History:
Business issued from the
merger of:
- RATIOPHARM CANADA INC.
- RATIOPHARM INC.
- TEVA CANADA LIMITED (a
former Company)
- NRX PHARMA CANADA INC.
- TECHNILAB PHARMA INC.
Business:
Teva Canada Limited develops, produces, and markets generic
pharmaceuticals.
It products range from diabetic agents to antibiotics from heart
medications to cancer treatments. The company also offers Teva Pharmacy
Solutions, a resource that gives access to the company’s accredited CEs and
publications, as well as opportunities in the areas of business, science, and
practice. It also sells its drugs online.
The company was founded in 1965 and is headquartered in Toronto, Canada.
Staff: 1,400
Operations & branches:
At above address, we find a
factory, warehouse and office, owned.
The Company maintains
factories located:
17800 Rue Lapointe
Mirabel, Quebec J7J 1P3 – Canada
5691 Main Street
Stouffville, Ontario L4A 1H5 Canada
Shareholders:
- 1377077 ONTARIO INC.
30 Novopharm Court, Toronto,
Ontario M1B 2K9- Canada
- ASAPH FARMACEUTISCHE ONDERNEMING B.V.
Computerweg 10 3542 DR Utrecht,
The Netherlands
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 Basel Street P.O. Box 3190 Petach
Tiqva 49131 Israel
Management:
Leslie L. DAN, Chairman and Director
Doug SUMMERVILLE, Vice
President and General Manager
Dominic DELLA PENNA, Vice President and CFO
Richard EGOSI, Director
Subsidiaries
And partnership: n/a
In Canada, privately held
corporations are not required to publish any financials.
On a direct call, a sales
assistant controlled the present report but deferred any financials.
However, estimate sales for
year 2013 is in the range of CAD 180,000,000=
The business is profitable.
Banks: Banque du Canada
Royal Bank
HSBC
...
Legal filings & complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary: Several
National Credit Bureaus
gave a satisfying credit rating.
According to our credit analysts, during the last 6 months, payments of
imports were currently made on terms.
The Company is developing a
strong business.
The Company is in good
standing.
This means that all local
and federal taxes were paid on due date.
The risk is low.
Our opinion:
A business connection may
be conducted.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.47 |
|
|
1 |
Rs.98.77 |
|
Euro |
1 |
Rs.77.65 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
SMN |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.